SGLT2 Inhibitors, GLP-1 Agonists, and DPP-4 Inhibitors in Diabetes and Microvascular Complications: A Review

The prevalence of diabetes and its associated complications is increasing throughout the decades. Promising diabetes medications were introduced to the market including GLP-1 agonists, DPP-4 inhibitors, and SGLT2 inhibitors aiming to target these complications. The literature lacks sufficient data r...

Descripción completa

Detalles Bibliográficos
Autores principales: El Mouhayyar, Christopher, Riachy, Ruba, Khalil, Abir Bou, Eid, Asaad, Azar, Sami
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066394/
https://www.ncbi.nlm.nih.gov/pubmed/32190049
http://dx.doi.org/10.1155/2020/1762164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066394/
https://www.ncbi.nlm.nih.gov/pubmed/32190049
http://dx.doi.org/10.1155/2020/1762164

Ejemplares similares